BMAC injection for severe knee osteoarthritis before knee surgery
Treatments studied
Part of Bones, joints & muscles clinical trials.
This trial studies injecting “bone marrow aspirate concentrate” (BMAC) into the knee to help relieve pain from severe knee osteoarthritis. It’s for people who have strong signs of advanced arthritis on X-ray and still have ongoing pain despite usual treatments, before a planned knee procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 45 and 75 years old
- Your knee X-rays show severe arthritis (Kellgren-Lawrence grade IV)
- Your doctor (primary care or orthopedist) says you need a total knee arthroscopy
- You have ongoing knee pain that hasn’t improved with standard treatments like pain medicines, physical therapy, or joint injections
- You’ve tried treatments such as acetaminophen, anti-inflammatory medicines, steroid or hyaluronic acid injections
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special injection of fat cells (MFAT) mixed with platelet-rich plasma (PRP) works better than either treatment alone for knee arthritis. It's for people with moderate to severe knee pain that hasn't improved with other treatments.
This study compares two different knee injections—one using your own concentrated bone marrow cells (BMAC) and the other using a steroid (cortisone)—to see which works better for long-term knee pain from osteoarthritis.
This trial tests if adding a bone marrow injection to standard knee arthroscopy helps your knee heal better. It is for people with a torn meniscus or damaged cartilage who have healthy knee joints without arthritis.
This study tests if a special concentrate made from your own bone marrow can help reduce pain from knee osteoarthritis. You may qualify if you have moderate to severe knee arthritis and haven't found relief from standard treatments.
This trial tests a new treatment for knee osteoarthritis using a concentrated sample of your own bone marrow cells. It compares this to a standard treatment to see if it helps reduce pain and improve function.
This trial compares different knee injections made from your own bone marrow and/or fat, plus platelet-rich plasma (a blood-derived healing factor), against saline (placebo) to treat painful knee osteoarthritis. It aims to see whether these “autologous” injections reduce knee pain and improve function.
Hear when a new Osteo Arthritis Knee trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.